rs2273500
Positions:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_000744.7(CHRNA4):c.383+378A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.156 in 1,305,208 control chromosomes in the GnomAD database, including 17,164 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.16 ( 2035 hom., cov: 32)
Exomes 𝑓: 0.16 ( 15129 hom. )
Consequence
CHRNA4
NM_000744.7 intron
NM_000744.7 intron
Scores
7
Splicing: ADA: 0.00006553
2
Clinical Significance
Conservation
PhyloP100: -6.67
Genes affected
CHRNA4 (HGNC:1958): (cholinergic receptor nicotinic alpha 4 subunit) This gene encodes a nicotinic acetylcholine receptor, which belongs to a superfamily of ligand-gated ion channels that play a role in fast signal transmission at synapses. These pentameric receptors can bind acetylcholine, which causes an extensive change in conformation that leads to the opening of an ion-conducting channel across the plasma membrane. This protein is an integral membrane receptor subunit that can interact with either nAChR beta-2 or nAChR beta-4 to form a functional receptor. Mutations in this gene cause nocturnal frontal lobe epilepsy type 1. Polymorphisms in this gene that provide protection against nicotine addiction have been described. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_addAF=-0.955197).
BP6
Variant 20-63355597-T-C is Benign according to our data. Variant chr20-63355597-T-C is described in ClinVar as [Benign]. Clinvar id is 3255299.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr20-63355597-T-C is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.295 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CHRNA4 | NM_000744.7 | c.383+378A>G | intron_variant | ENST00000370263.9 | NP_000735.1 | |||
CHRNA4 | NM_001256573.2 | c.-146+360A>G | intron_variant | NP_001243502.1 | ||||
CHRNA4 | NR_046317.2 | n.592+378A>G | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CHRNA4 | ENST00000370263.9 | c.383+378A>G | intron_variant | 1 | NM_000744.7 | ENSP00000359285.4 |
Frequencies
GnomAD3 genomes AF: 0.160 AC: 24284AN: 152010Hom.: 2032 Cov.: 32
GnomAD3 genomes
AF:
AC:
24284
AN:
152010
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.164 AC: 22355AN: 136100Hom.: 2096 AF XY: 0.175 AC XY: 12933AN XY: 74082
GnomAD3 exomes
AF:
AC:
22355
AN:
136100
Hom.:
AF XY:
AC XY:
12933
AN XY:
74082
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.156 AC: 179348AN: 1153080Hom.: 15129 Cov.: 30 AF XY: 0.160 AC XY: 90597AN XY: 565876
GnomAD4 exome
AF:
AC:
179348
AN:
1153080
Hom.:
Cov.:
30
AF XY:
AC XY:
90597
AN XY:
565876
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.160 AC: 24312AN: 152128Hom.: 2035 Cov.: 32 AF XY: 0.164 AC XY: 12190AN XY: 74382
GnomAD4 genome
AF:
AC:
24312
AN:
152128
Hom.:
Cov.:
32
AF XY:
AC XY:
12190
AN XY:
74382
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
522
ALSPAC
AF:
AC:
556
ExAC
AF:
AC:
3506
Asia WGS
AF:
AC:
746
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan | Jul 15, 2024 | This variant is classified as Benign based on local population frequency. This variant was detected in 29% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 27. Only high quality variants are reported. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at